New Drugs Archive

Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations

Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations Print this page BOULDER, Colo., June 27, 2018 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that the …